203 related articles for article (PubMed ID: 22479882)
1. Buprenorphine therapy for opioid addiction in rural Washington: the experience of the early adopters.
Quest TL; Merrill JO; Roll J; Saxon AJ; Rosenblatt RA
J Opioid Manag; 2012; 8(1):29-38. PubMed ID: 22479882
[TBL] [Abstract][Full Text] [Related]
2. Barriers to primary care physicians prescribing buprenorphine.
Hutchinson E; Catlin M; Andrilla CH; Baldwin LM; Rosenblatt RA
Ann Fam Med; 2014; 12(2):128-33. PubMed ID: 24615308
[TBL] [Abstract][Full Text] [Related]
3. Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians.
Andrilla CHA; Moore TE; Patterson DG
J Rural Health; 2019 Jan; 35(1):113-121. PubMed ID: 30339720
[TBL] [Abstract][Full Text] [Related]
4. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
[TBL] [Abstract][Full Text] [Related]
5. Prescribing Practices of Rural Physicians Waivered to Prescribe Buprenorphine.
Andrilla CHA; Coulthard C; Patterson DG
Am J Prev Med; 2018 Jun; 54(6 Suppl 3):S208-S214. PubMed ID: 29779544
[TBL] [Abstract][Full Text] [Related]
6. Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder.
Andrilla CHA; Coulthard C; Larson EH
Ann Fam Med; 2017 Jul; 15(4):359-362. PubMed ID: 28694273
[TBL] [Abstract][Full Text] [Related]
7. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.
DeFlavio JR; Rolin SA; Nordstrom BR; Kazal LA
Rural Remote Health; 2015; 15():3019. PubMed ID: 25651434
[TBL] [Abstract][Full Text] [Related]
8. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
Rhee TG; Rosenheck RA
Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine prescribing practice trends and attitudes among New York providers.
Kermack A; Flannery M; Tofighi B; McNeely J; Lee JD
J Subst Abuse Treat; 2017 Mar; 74():1-6. PubMed ID: 28132694
[TBL] [Abstract][Full Text] [Related]
10. Projected Contributions of Nurse Practitioners and Physicians Assistant to Buprenorphine Treatment Services for Opioid Use Disorder in Rural Areas.
Andrilla CHA; Patterson DG; Moore TE; Coulthard C; Larson EH
Med Care Res Rev; 2020 Apr; 77(2):208-216. PubMed ID: 30089426
[TBL] [Abstract][Full Text] [Related]
11. Barriers and facilitators to nurse practitioner buprenorphine prescribing for opioid use disorder in primary care settings.
Speight C; Caiola C; Tyndall DE; Scott ES
J Am Assoc Nurse Pract; 2023 Feb; 35(2):112-121. PubMed ID: 36512806
[TBL] [Abstract][Full Text] [Related]
12. Practice Predictors of Buprenorphine Prescribing by Family Physicians.
Peterson LE; Morgan ZJ; Borders TF
J Am Board Fam Med; 2020; 33(1):118-123. PubMed ID: 31907252
[TBL] [Abstract][Full Text] [Related]
13. Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.
Wen H; Hockenberry JM; Pollack HA
JAMA Netw Open; 2018 Sep; 1(5):e182943. PubMed ID: 30646185
[TBL] [Abstract][Full Text] [Related]
14. A survey of barriers and facilitators to the adoption of buprenorphine prescribing after implementation of a New Jersey-wide incentivized DATA-2000 waiver training program.
Nyaku AN; Zerbo EA; Chen C; Milano N; Johnston B; Chadwick R; Marcello S; Baston K; Haroz R; Crystal S
BMC Health Serv Res; 2024 Feb; 24(1):179. PubMed ID: 38331802
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine Prescribing and Challenges Faced Among National Health Service Corps Clinicians.
Rowan K; Shah SV; Binns S; Murphy E; Satorius J; Ghobadi A; Krauss D; Robbins C; Schoebel V; Knudson A; Kepley H;
JAMA Netw Open; 2024 May; 7(5):e2411742. PubMed ID: 38758556
[TBL] [Abstract][Full Text] [Related]
16. Prescribing Practices of Nurse Practitioners and Physician Assistants Waivered to Prescribe Buprenorphine and the Barriers They Experience Prescribing Buprenorphine.
Andrilla CHA; Jones KC; Patterson DG
J Rural Health; 2020 Mar; 36(2):187-195. PubMed ID: 31650634
[TBL] [Abstract][Full Text] [Related]
17. In Rural Areas, Buprenorphine Waiver Adoption Since 2017 Driven By Nurse Practitioners And Physician Assistants.
Barnett ML; Lee D; Frank RG
Health Aff (Millwood); 2019 Dec; 38(12):2048-2056. PubMed ID: 31794302
[TBL] [Abstract][Full Text] [Related]
18. Barriers and facilitators to office-based opioid agonist therapy prescribing and effective interventions to increase provider prescribing: protocol for a systematic review.
Nixon LL; Marlinga JC; Hayden KA; Mrklas KJ
Syst Rev; 2019 Jul; 8(1):186. PubMed ID: 31345258
[TBL] [Abstract][Full Text] [Related]
19. Decline in Buprenorphine/Naloxone Prescriptions in a State Medicaid Population Following Formulary Conversion from Suboxone to Bunavail.
Soper R; Appajosyula S; Deximo C
Adv Ther; 2018 Apr; 35(4):457-466. PubMed ID: 29623562
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
Jones CM; McCance-Katz EF
Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
